Queen Mary University of London has launched a new spinout company, Elcella, founded by Dr Madusha Peiris and Dr Rubina Aktar. Their unique nutrient-based appetite suppressant stimulates your body’s natural ability to control your eating – based on a decade of scientific research.
A major study aiming to improve outcomes from higher risk operations has ruled out a fluid therapy approach during surgery.
A genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the disease.